lexatumumab
mapatumumab
conatumumab
panitumumab
oleclumab
patritumab
tenatumomab
tigatuzumab
sibrotuzumab
inotuzumab
duligotuzumab
acrixolimab
matuzumab
dalotuzumab
lintuzumab
figitumumab
drozitumab
naptumomab estafenatox
inotuzumab ozogamicin
onartuzumab
pamrevlumab
iratumumab
nofetumomab
dacetuzumab
samalizumab
agonistic monoclonal antibody
avelumab
adecatumumab
pritumumab
teprotumumab
brentuximab
lucatumumab
durvalumab
carlumab
cergutuzumab
bivatuzumab
apolizumab
catumaxomab
ertumaxomab
alacizumab
oportuzumab monatox
elotuzumab
tucotuzumab
sonepcizumab
teplizumab
dorlixizumab
cixutumumab
ocrelizumab
ramucirumab
amivantamab